Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Bites and Stings × Levobupivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7 Pain, Postoperative 2 Agnosia 2 Pancreatic Neoplasms 1 Neoplasms 1 Musculoskeletal Pain 1 Hypotension 1 Head and Neck Neoplasms 1 Erector Spinae Block Analgesia 1 Brain Neoplasms 1 Bradycardia 1 Bites and Stings 1 Abdominal Cancer Surgery 1

Interventions

Stents 2 soybean oil, phospholipid emulsion 1 camrelizumab 1 Surgical Procedures, Operative 1 Surgical Instruments 1 Radiotherapy, Conformal 1 Radiotherapy 1 Passive Cutaneous Anaphylaxis 1 Palliative Care 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 Neoadjuvant Therapy 1 Morphine 1 Lidocaine 1 Levobupivacaine 1 Immunotherapy 1 Cryotherapy 1 ClinOleic 1 Bupivacaine 1 Argon Plasma Coagulation 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02121951 2018-04-10

QLB

National Cancer Institute, Egypt

Phase 4 Withdrawn

Bites and Stings, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡